Litcius/Paper detail

Teclistamab: First Approval

Connie Kang

2022Drugs84 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMultiple myelomaRefractory (planetary science)Proteasome inhibitorOncologyInternal medicineAntibodyDaratumumabBortezomibCD38ImmunologyStem cellBiologyAstrobiologyPhysicsGeneticsCD34Multiple Myeloma Research and TreatmentsCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies Research
Teclistamab: First Approval | Litcius